Seminal studies in non-cancer cells used anti-mitotic agents, such as taxols, to prolong mitosis, revealing that over a certain time threshold, they activated p53 and initiated a p53-dependent G1 arrest in daughter cells in the absence of chromosome segregation errors or detectable DNA damage (Uetake and Sluder, 2010). The gene discussed is TP53; the disease is cancer.